| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/28/2010 | WO2009125987A9 Pharmaceutical formulation |
| 01/28/2010 | WO2009125944A9 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker |
| 01/28/2010 | WO2009124962A3 Sulfonamides |
| 01/28/2010 | WO2009123714A3 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| 01/28/2010 | WO2009122176A3 Rapamycin carbonate esters |
| 01/28/2010 | WO2009120978A3 Treatment of metabolic-related disorders using hypothalamic gene transfer of bdnf and compositions therfor |
| 01/28/2010 | WO2009120844A3 Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue |
| 01/28/2010 | WO2009120094A3 Substituted pyrimidines and triazines and their use in cancer therapy |
| 01/28/2010 | WO2009118753A3 Process for preparation of naratriptan hydrochloride |
| 01/28/2010 | WO2009117130A3 Extended release forumulation containing a wax |
| 01/28/2010 | WO2009111428A4 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof |
| 01/28/2010 | WO2009107850A3 Fused heterocyclic derivative and use thereof |
| 01/28/2010 | WO2009106019A3 Chemical compounds having antiviral activity against dengue virus and other flaviviruses |
| 01/28/2010 | WO2009101018A3 3-alkyl-piperazine derivatives and uses thereof |
| 01/28/2010 | WO2009090656A3 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 01/28/2010 | WO2009078034A3 Orally disintegrating tablets of ropinirole hydrochloride |
| 01/28/2010 | WO2009077497A3 Azolyl methyl oxiranes, the use thereof, and agents containing them |
| 01/28/2010 | WO2009073661A3 Compositions comprising coenzyme q-io and garlic oil for an increased coenzyme q-10 bioavailability |
| 01/28/2010 | WO2009047826A8 Pharmaceutical composition comprising sucralphate and mesalazine |
| 01/28/2010 | WO2009024631A3 A combination of inhibitors of tgfbeta-1 and matrix metalloproteins for use in the treatment of bone metastases, bone resorption and hypercalcaemia |
| 01/28/2010 | WO2009009768A8 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 01/28/2010 | WO2008155075A3 Shampoo composition having improved care properties |
| 01/28/2010 | WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/28/2010 | WO2008135746A3 Natural bioactive compounds |
| 01/28/2010 | WO2008125843A9 Pharmaceutical compositions |
| 01/28/2010 | US20100023111 SURFACE MODIFICATION OF ePTFE AND IMPLANTS USING THE SAME |
| 01/28/2010 | US20100023101 Biocompatible composites |
| 01/28/2010 | US20100022997 Method and process for producing youthful-appearing, small-pored, and smooth skin |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022659 Methods and Compositions for the Treatment of CNS-Related Conditions |
| 01/28/2010 | US20100022658 Methods for treating cognitive impairment in humans |
| 01/28/2010 | US20100022657 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 01/28/2010 | US20100022656 Optically active phenylethanol amines and preparing method thereof |
| 01/28/2010 | US20100022655 Therapeutic Agents For The Treatment Of Lymphoid Malignancies |
| 01/28/2010 | US20100022653 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil |
| 01/28/2010 | US20100022652 Antimicrobial and Anticoagulant Compositions and Methods |
| 01/28/2010 | US20100022651 Method For Increasing Hair Growth |
| 01/28/2010 | US20100022650 Benzamide Derivatives As EP4 Receptor Agonists |
| 01/28/2010 | US20100022649 Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis From the Royal Palm (Roystonea regia) Fruits |
| 01/28/2010 | US20100022647 High arachidonic acid producing strains of yarrowia lipolytica |
| 01/28/2010 | US20100022646 method of neutralising organoboronates with acids |
| 01/28/2010 | US20100022645 PKC-Activating Compounds for the Treatment of Neurodegenerative Diseases |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022642 Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide |
| 01/28/2010 | US20100022641 Solid forms of selective androgen receptor modulators |
| 01/28/2010 | US20100022640 Esters of 2-phenylalkanenitriles and antifungal compositions containing them |
| 01/28/2010 | US20100022639 Methods of Inducing Weight Loss |
| 01/28/2010 | US20100022638 Isosorbide nitrates |
| 01/28/2010 | US20100022637 Identification of anti-cancer compounds and compounds for treating huntington's disease and methods of treatment thereof |
| 01/28/2010 | US20100022636 Compositions and Methods For Enhancing The Antioxidant Status of Animals |
| 01/28/2010 | US20100022635 Heat shock protein 90 inhibitor dosing methods |
| 01/28/2010 | US20100022634 Laidlomycin compositions and methods |
| 01/28/2010 | US20100022633 Cognitive abilities improving agent |
| 01/28/2010 | US20100022632 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases |
| 01/28/2010 | US20100022631 Treatment of hepatic encephalopathy and liver cirrhosis |
| 01/28/2010 | US20100022630 Method of treatment using fatty acid synthesis inhibitors |
| 01/28/2010 | US20100022629 Dietary Methods and Compositions for Enhancing Metabolism and Reducing Reactive Oxygen Species |
| 01/28/2010 | US20100022628 Alternative oxidase and uses thereof |
| 01/28/2010 | US20100022627 Predictive biomarkers for chronic allograft nephropathy |
| 01/28/2010 | US20100022626 Modulators of cell migration and methods of identifying same |
| 01/28/2010 | US20100022625 Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use |
| 01/28/2010 | US20100022624 Methods of Treating Smooth Muscle Cell Disorders |
| 01/28/2010 | US20100022623 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 01/28/2010 | US20100022622 Dbait and its Standalone Uses Thereof |
| 01/28/2010 | US20100022621 Construction and use of transfection enhancer elements |
| 01/28/2010 | US20100022620 Epitope reduction therapy |
| 01/28/2010 | US20100022619 Compositions and their uses directed to ptpr alpha |
| 01/28/2010 | US20100022618 Long interfering nucleic acid duplexes targeting multiple RNA targets |
| 01/28/2010 | US20100022617 Compositions and methods to control abnormal cell growth |
| 01/28/2010 | US20100022616 3-(phenoxyphenylmethyl)pyrrolidine compounds |
| 01/28/2010 | US20100022615 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions |
| 01/28/2010 | US20100022614 Pharmaceutical composition for external application and adhesive skin patch |
| 01/28/2010 | US20100022613 Compounds Having CRTH2 Antagonist Activity |
| 01/28/2010 | US20100022612 Fused heterocycles |
| 01/28/2010 | US20100022611 1,5-Diaryl-Pyrazoles As Cannabinoid Receptor Neutral Antagonists Useful As Therapeutic Agents |
| 01/28/2010 | US20100022610 New Crystalline Forms |
| 01/28/2010 | US20100022609 Novel crystalline forms of temozolomide |
| 01/28/2010 | US20100022608 Non-steroidal anti-inflammatory drugs for cough |
| 01/28/2010 | US20100022607 Diazonamide analogs |
| 01/28/2010 | US20100022605 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/28/2010 | US20100022604 Prophylactic or therapeutic agent for alopecia |
| 01/28/2010 | US20100022603 Peroxisome proliferator-activated receptor agonists; insulin resistance; metabolic diseases; diabetes; dyslipidemia; 2-Ethoxy-N-[5-(5-isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-indan-2-yl]-4-trifluoromethyl-benzamide |
| 01/28/2010 | US20100022602 Pre-mixed, ready-to-use iv bolus nicardipine compositions and methods of use |
| 01/28/2010 | US20100022601 Sulfonamide compounds and the use |
| 01/28/2010 | US20100022600 Methods and compositions for treating central nervous system tumors |
| 01/28/2010 | US20100022599 imidazole or triazole derivatives such as 4-[4-((R)-1-Benzyl-2-hydroxycarbamoylethylcarbamoyl)-2-butylimidazol-1-ylmethyl]benzoic acid methyl ester, used for treating congestive heart failure or as hypotensive agents |
| 01/28/2010 | US20100022598 Substituted inmidazoles as bombesin receptor subtype-3 modulators |
| 01/28/2010 | US20100022597 2-adamantyl-butyramide derivatives as selective 11beta-hsd1 inhibitors |
| 01/28/2010 | US20100022596 Epothilone analogues |
| 01/28/2010 | US20100022595 Benzenesulfonamide Compounds and Their Use as Blockers of Calcium Channels |
| 01/28/2010 | US20100022594 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome |
| 01/28/2010 | US20100022593 Process for Producing Anticancer Agent LL-D45042 |
| 01/28/2010 | US20100022592 Thiazole derivatives as modulators of g protein-coupled receptors |
| 01/28/2010 | US20100022591 Piperidine gpcr agonists |
| 01/28/2010 | US20100022590 Novel compounds |
| 01/28/2010 | US20100022589 Pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase |
| 01/28/2010 | US20100022588 Pharmaceutical carrier composition and pharmaceutical composition |
| 01/28/2010 | US20100022587 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
| 01/28/2010 | US20100022586 Bicyclic heteroaryl inhibitors of pde4 |
| 01/28/2010 | US20100022585 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |